These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26744845)

  • 1. Integrating Microarrays into Routine Prenatal Diagnosis: Determinants of Decision Making.
    Cordoba M; Andriole S; Evans SM; Britt D; Chu Lam M; Evans MI
    Fetal Diagn Ther; 2016; 40(2):135-40. PubMed ID: 26744845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model.
    Heckerling PS; Verp MS; Hadro TA
    J Clin Epidemiol; 1994 Nov; 47(11):1215-28. PubMed ID: 7722557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases.
    Fiorentino F; Caiazzo F; Napolitano S; Spizzichino L; Bono S; Sessa M; Nuccitelli A; Biricik A; Gordon A; Rizzo G; Baldi M
    Prenat Diagn; 2011 Dec; 31(13):1270-82. PubMed ID: 22034057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases.
    Van den Veyver IB; Patel A; Shaw CA; Pursley AN; Kang SH; Simovich MJ; Ward PA; Darilek S; Johnson A; Neill SE; Bi W; White LD; Eng CM; Lupski JR; Cheung SW; Beaudet AL
    Prenat Diagn; 2009 Jan; 29(1):29-39. PubMed ID: 19012303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The choices women make about prenatal diagnosis.
    Evans MI; Pryde PG; Evans WJ; Johnson MP
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):70-80. PubMed ID: 11653025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting.
    Maya I; Davidov B; Gershovitz L; Zalzstein Y; Taub E; Coppinger J; Shaffer LG; Shohat M
    Prenat Diagn; 2010 Dec; 30(12-13):1131-7. PubMed ID: 20925131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
    Pryde PG; Drugan A; Johnson MP; Isada NB; Evans MI
    Clin Obstet Gynecol; 1993 Sep; 36(3):496-509. PubMed ID: 8403601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
    Vestergaard CH; Lidegaard Ø; Tabor A
    Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of array CGH in the management of fetal nuchal translucency].
    Beal J; Jedraszak G; Saliou AH; Copin H; Sergent F; Gondry J; Merviel P; Muszynski C
    Gynecol Obstet Fertil Senol; 2020 Feb; 48(2):174-180. PubMed ID: 31634590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening and its impact on uptake of diagnostic testing.
    Darnes DR; Hashmi S; Monga M; Sullivan C; Vidaeff A; Berens P; Czerwinski JL
    Prenat Diagn; 2011 Sep; 31(9):892-6. PubMed ID: 21692093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive behaviour and prenatal diagnosis following genetic termination of pregnancy in women of advanced maternal age.
    Brandenburg H; De Koning W; Jahoda MG; Stijnen T; De Ridder MA; Sachs ES; Wladimiroff JW
    Prenat Diagn; 1992 Dec; 12(12):1031-5. PubMed ID: 1287638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of physician preferences in the choice of amniocentesis or chorionic villus sampling for prenatal genetic testing.
    Heckerling PS; Verp MS; Albert N
    Genet Test; 1998; 2(1):61-6. PubMed ID: 10464598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing indications for invasive testing in an era of improved screening.
    Norton ME; Rink BD
    Semin Perinatol; 2016 Feb; 40(1):56-66. PubMed ID: 26725145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.
    Gil MM; Giunta G; Macalli EA; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):67-73. PubMed ID: 25302655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. aCGH on chorionic villi mirrors the complexity of fetoplacental mosaicism in prenatal diagnosis.
    Filges I; Kang A; Klug V; Wenzel F; Heinimann K; Tercanli S; Miny P
    Prenat Diagn; 2011 May; 31(5):473-8. PubMed ID: 21351283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis in advanced maternal age. Amniocentesis or CVS, a patient's choice or lack of information?
    Brandenburg H; van der Zwan L; Jahoda MG; Stijnen T; Wladimiroff JW
    Prenat Diagn; 1991 Sep; 11(9):685-90. PubMed ID: 1788174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.